Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2012 - 2026)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Exchange Rate Effect of -$400000.0 in Q1 2026, down 1312.12% quarter-over-quarter from $33000.0 in Q4 2025, and down 123.53% on a YoY basis from $1.7 million in Q1 2025.
Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2012 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at -$400000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 123.53% year-over-year to -$400000.0; the TTM figure through Mar 2026 stood at $4.5 million (up 158.56% YoY), while the FY2025 annual figure was $6.6 million, up 491.34% from the prior year.
- Exchange Rate Effect was -$400000.0 for Q1 2026 at Jazz Pharmaceuticals, down from $33000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.9 million in Q4 2022 to a low of -$5.4 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$35588.2 across 5 years, with a median of $33000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect plunged 2332.35% in 2024, then surged 708.56% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $4.9 million in 2022, then slumped by 63.75% to $1.8 million in 2023, then sank by 227.95% to -$2.3 million in 2024, then surged by 101.44% to $33000.0 in 2025, then sank by 1312.12% to -$400000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$400000.0 (Q1 2026), $33000.0 (Q4 2025), and $203000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | -400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -400,000.00 |
| Mar 31, 2026 | -400,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | 203,000.00 |
| Sep 30, 2025 | 203,000.00 |
| Jun 30, 2025 | 4.62 Mn |
| Jun 30, 2025 | 4.62 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | -2.29 Mn |
| Dec 31, 2024 | -2.29 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | -759,000.00 |
| Jun 30, 2024 | -759,000.00 |
| Mar 31, 2024 | -1.70 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |